Inventor · disambiguated record
Sool Ki Kwon
Also filed as: KWON SOOL-KI
4 granted patents·2 pending applications·34 citations·filing 2013–2022
70Inventor score
Top patents by PatentIndex Score
6 records- 0191US9758508B22,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including sameCRYSTALGENOMICS INC·Filed 2013·Granted Sep 12, 2017·33 cites·15 claims
- 0275US12338237B2Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2020·Granted Jun 24, 2025·1 cites·18 claims
- 0371US2022380346A12,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition including sameCRYSTALGENOMICS INC·Filed 2022·Application pending·0 cites
- 0464US11230539B22,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including sameCRYSTALGENOMICS INC·Filed 2020·Granted Jan 25, 2022·0 cites·22 claims
- 0562US10604508B22,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including sameCRYSTALGENOMICS INC·Filed 2017·Granted Mar 31, 2020·0 cites·22 claims
- 0652US2024262819A1Novel compounds having inhibitory activity against glucosylceramide synthase or pharmaceutically acceptable salt thereof, processes for preparing the same, and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sool Ki Kwon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →